Aegera Therapeutics, part of Pharmascience Inc., is focused on developing targeted therapeutics to address major unmet medical needs.

Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain.

Aegera is also dedicated to identifying novel development candidates based upon its core technologiesand internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials.